Medicine and Dentistry
Salivary Gland
99%
Sjoegren Syndrome
71%
Parotid Gland
67%
Rituximab
46%
Implant Placement
44%
MALT Lymphoma
42%
B Cell
36%
Implant
31%
Botulinum Toxin A
28%
Alveolar Ridge
28%
Systemic Disease
28%
Leiomyosarcoma
28%
Biopsy Technique
27%
Salivary Gland Function
24%
Diseases
23%
Tooth Extraction
23%
Diagnosis
22%
Mucosa-Associated Lymphoid Tissue
22%
Controlled Clinical Trial
21%
Xerostomia
21%
Sialography
20%
T Cell
20%
Salivary Gland Disease
18%
Obstruction
18%
Disease Duration
17%
Randomized Controlled Trial
17%
Disease
17%
Cosmetics
15%
Maxillofacial Surgeon
15%
Dentist
15%
Surgery
15%
Submandibular Gland
15%
Cosmetic Facial Surgery
14%
Clinical Study
14%
Lipiodol
14%
Osteotomy
14%
Gastrointestinal Stromal Tumor
14%
Quality of Life
14%
Surgical Technique
14%
Randomized Clinical Trial
14%
Patient-Reported Outcome
14%
Immunohistology
14%
Mandibular Advancement
14%
Biological Product
14%
Bariatric Surgery
14%
ABC Transporter Subfamily B
14%
Monotherapy
14%
Neoplasm
14%
Angioleiomyoma
14%
Case-Control Study
14%
Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
100%
Sjoegren Syndrome
42%
Botulinum Toxin A
42%
Cosmetics
42%
Diseases
38%
Rituximab
28%
Leiomyosarcoma
28%
Obstruction
23%
Marginal Zone Lymphoma
21%
Xerostomia
20%
Disease Duration
19%
Gastrointestinal Stromal Tumor
14%
Salivary Gland Disease
14%
Leiomyoma
14%
Biological Product
14%
Case-Control Study
14%
Normal Human
14%
Systemic Disease
14%
Monotherapy
14%
P-Glycoprotein
14%
Neoplasm
14%
Ethanol
11%
Neurotoxin
11%
Chimeric Antibody
9%
Side Effect
9%
Stenosis
9%
Botulism
8%
Placebo
7%
Remission
6%
Hyperactivity
6%
Hypersalivation
6%
Acetylcholine
5%
Autoimmune Disease
5%
Immunology and Microbiology
B Cell
37%
Salivary Gland Function
29%
Sjögren's Syndrome
28%
Autoimmune Disease
26%
Salivary Gland
22%
T Cell
19%
Mucosa-Associated Lymphoid Tissue
19%
Flow Rate
19%
Biological Product
14%
Mouth
14%
Rituximab
14%
Salivation
14%
Peptides
14%
Proteomics
14%
Normal Human
10%
Antigen Presentation
7%
Western Blot
7%
Interferon Type I
7%
Real-Time Polymerase Chain Reaction
7%
Immune Response
7%
Tumor Necrosis Factor Alpha
7%
CD20
7%
CD22
7%
Lymphocyte
7%
Parotid Gland
6%
Chimeric Antibody
5%